Vaginal Estradiol Cost in South Dakota (2026): Prices, Insurance, and Savings

What Does Vaginal Estradiol Cost at South Dakota Pharmacies?

The retail price you pay depends on whether you fill a brand-name or generic prescription and which pharmacy you use. Across South Dakota retail pharmacies in 2026, the average cash-pay price for vaginal estradiol is approximately $120 per month. The manufacturer list price for brand-name formulations (such as Estrace cream or the Estring vaginal ring) sits near $280 per month.

These prices reflect a pattern seen nationally. According to a 2023 analysis published in Menopause, out-of-pocket costs for vaginal estrogen products remain a significant barrier to adherence, with cash prices varying by up to 60% between pharmacies within the same metropolitan area [1]. South Dakota's pharmacy field is no exception. Rural pharmacies in western South Dakota may carry higher prices than Sioux Falls or Rapid City locations due to lower prescription volume and limited competition.

Generic vaginal estradiol cream (estradiol vaginal cream, 0.01%) typically costs less than brand-name Estrace. The vaginal tablet form (generic for Vagifem) and the vaginal ring (Estring) each occupy different price tiers. Estring, which delivers a consistent low dose of 7.5 mcg per 24 hours over 90 days, may appear more expensive upfront ($200 to $400 per ring) but works out to roughly $67 to $133 per month when calculated over its three-month lifespan.

Prescription discount tools like GoodRx and RxSaver can reduce cash prices at South Dakota chain pharmacies (Walgreens, CVS inside Target, Lewis Drug, and Hy-Vee Pharmacy) by 20% to 50% depending on the formulation and location. Always compare prices across at least two pharmacies before filling.

The FDA-approved labeling for vaginal estradiol specifies its indication for moderate-to-severe symptoms of vulvar and vaginal atrophy due to menopause, reinforcing that this is a medically indicated therapy rather than an elective product.

South Dakota Medicaid Does Not Cover Vaginal Estradiol for GSM

South Dakota Medicaid does not list vaginal estradiol as a covered drug for genitourinary syndrome of menopause (GSM). This coverage gap leaves Medicaid enrollees without a pharmacy benefit for one of the most effective treatments for vulvovaginal atrophy, a condition affecting up to 84% of postmenopausal women according to the North American Menopause Society (NAMS) [2].

The absence of Medicaid coverage in South Dakota contrasts with states like New York and California, where vaginal estrogen products are included on preferred drug lists. For South Dakota Medicaid beneficiaries, the options are limited: pay out of pocket at the cash-pay price, seek a compounded alternative through a 503A pharmacy, or apply for a manufacturer patient assistance program.

Allergan (now AbbVie) offers a patient assistance program for Estrace vaginal cream that covers qualifying uninsured or underinsured patients. Eligibility typically requires household income below 200% to 300% of the federal poverty level. Application forms are available through the manufacturer's website or through NeedyMeds, a nonprofit clearinghouse for patient assistance programs.

The 2022 Endocrine Society Clinical Practice Guideline on menopause management recommends low-dose vaginal estrogen as first-line therapy for GSM symptoms, noting that systemic absorption is minimal and the benefit-risk profile is favorable even in women with a history of breast cancer on aromatase inhibitors [3]. South Dakota's Medicaid exclusion runs counter to this guideline recommendation.

Is Compounded Vaginal Estradiol Legal in South Dakota?

Yes. Compounded vaginal estradiol is available in South Dakota through 503A-licensed compounding pharmacies. These pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription from a licensed prescriber [4].

South Dakota's Board of Pharmacy regulates compounding pharmacies within the state. A 503A pharmacy in South Dakota can compound vaginal estradiol cream, suppositories, or capsules in strengths and bases tailored to individual patient needs. This can include estriol/estradiol combination preparations (sometimes marketed as "Biest" formulations), though the clinical evidence base for these combinations is thinner than for estradiol alone.

The cost advantage is real. Some 503A compounding pharmacies in South Dakota offer vaginal estradiol preparations for substantially less than the brand-name retail price, with some patients reporting costs under $40 per month depending on the formulation. Prices vary by pharmacy, compounding base, and concentration.

A few considerations apply. Compounded products are not FDA-approved and do not undergo the same manufacturing consistency testing as commercially manufactured drugs. The 2020 NAMS position statement acknowledges that compounded hormones may be appropriate when a patient requires a dose or delivery form not commercially available, but advises that FDA-approved products be used when possible due to established quality controls [5].

South Dakota does not restrict telehealth prescribing of compounded hormones, so a prescriber in another state (licensed in South Dakota) can write a prescription that a South Dakota 503A pharmacy fills. This opens access for patients in rural areas far from both prescribers and compounding pharmacies.

Insurance Coverage for Vaginal Estradiol in South Dakota

Commercial insurance plans in South Dakota handle vaginal estradiol coverage inconsistently. Large employer-sponsored plans through carriers like Avera Health Plans, Sanford Health Plan, and UnitedHealthcare of the Midlands generally include at least one vaginal estrogen formulation on their formulary, often with a Tier 2 or Tier 3 copay.

Formulary placement determines your cost. A Tier 2 preferred generic might carry a $15 to $30 copay per fill. A Tier 3 preferred brand could mean $50 to $75. Non-preferred brand products pushed to Tier 4 or requiring prior authorization may cost $100 or more per fill, sometimes approaching the cash price.

The specific formulation matters. Many South Dakota insurers prefer the generic vaginal estradiol tablet (the generic equivalent of Vagifem/Yuvafem) over vaginal cream because tablet dosing is more precise and waste is lower. If your plan covers the tablet but you prefer the cream, you may need your prescriber to submit a prior authorization explaining clinical necessity (for example, if the tablet applicator causes discomfort).

For patients on Medicare Part D in South Dakota, vaginal estradiol is typically covered, though the plan's specific formulary and cost-sharing tier vary. The 2025 Medicare Part D redesign capped annual out-of-pocket drug spending at $2,000, which may benefit patients taking multiple medications alongside vaginal estradiol [6].

A 2019 study in the Journal of Women's Health found that formulary restrictions on vaginal estrogen products were associated with a 23% reduction in prescription fills and a corresponding increase in urinary tract infections among postmenopausal women, resulting in higher overall healthcare costs [7]. This finding is relevant to South Dakota's insurance field, where prior authorization barriers can delay treatment initiation.

How Savings Cards and Discount Programs Work in South Dakota

Manufacturer savings cards (sometimes called copay cards or copay coupons) can offset insurance copays for brand-name vaginal estradiol products. These cards are funded by the drug manufacturer and typically reduce your copay to $0 to $25 per fill.

Here is how they work in practice. You present the savings card at the pharmacy along with your insurance card. The pharmacist processes your insurance first, then applies the savings card to reduce or eliminate your remaining copay. Most cards have a maximum annual benefit (often $1,200 to $2,400 per year) and an expiration date.

Key restrictions apply in South Dakota:

• Government insurance exclusion. Federal anti-kickback statutes prohibit using manufacturer copay cards with Medicare, Medicaid, TRICARE, or VA benefits. Since South Dakota Medicaid does not cover vaginal estradiol anyway, this exclusion is less immediately relevant, but Medicare Part D enrollees cannot use these cards.
• Commercial insurance requirement. Most savings cards require active commercial insurance. Cash-pay patients are sometimes eligible for a separate patient assistance program but not the copay card itself.
• Pharmacy participation. Nearly all chain pharmacies in South Dakota accept manufacturer copay cards. Independent pharmacies may also participate, but confirm before filling.

For uninsured patients, prescription discount platforms (GoodRx, SingleCare, RxAssist) aggregate negotiated rates from pharmacy benefit managers. In South Dakota, GoodRx coupons have historically reduced the cash price of generic vaginal estradiol cream to the $30 to $60 range at participating pharmacies, though prices fluctuate monthly.

The Estrace savings program and the Imvexxy (estradiol vaginal insert) copay card are two manufacturer-specific programs currently active. Imvexxy's softgel insert delivers 4 mcg or 10 mcg of estradiol and was shown in a phase 3 trial (N=576) to produce statistically significant improvement in vaginal pH, parabasal cell percentage, and most bothersome symptom scores compared to placebo at 12 weeks [8].

Telehealth Prescribing of Vaginal Estradiol in South Dakota

South Dakota permits telehealth prescribing of vaginal estradiol. A prescriber licensed in South Dakota can evaluate a patient via synchronous video or audio visit and issue a prescription without an in-person examination, provided the standard of care is met.

This matters for access. South Dakota ranks 48th among U.S. States in physicians per capita, and many counties in western South Dakota have no OB-GYN or menopause specialist within 60 miles. Telehealth eliminates the geographic barrier for a condition (GSM) that is straightforward to diagnose based on history and symptoms in most cases.

Several national telehealth platforms now offer menopause-focused consultations that include vaginal estradiol prescribing. These platforms typically charge $50 to $150 per consultation and can send prescriptions to any South Dakota pharmacy, including 503A compounding pharmacies.

The 2022 Cochrane Review of low-dose vaginal estrogen for GSM, which included 30 trials and over 6,000 women, confirmed that all vaginal estrogen formulations (cream, tablet, ring) are effective for relieving vaginal dryness and dyspareunia, with no significant differences in efficacy between formulations [9]. This evidence supports the telehealth prescribing model: a clinician can confidently prescribe any vaginal estradiol formulation based on patient preference, cost, and insurance coverage without needing a physical exam for initial prescription in uncomplicated cases.

South Dakota law does not require an initial in-person visit before establishing a telehealth prescriber-patient relationship for non-controlled substances. Vaginal estradiol is not a controlled substance, so the telehealth pathway is fully available from the first visit.

Choosing the Right Formulation Based on Cost and Preference

Three FDA-approved vaginal estradiol delivery systems exist, and cost in South Dakota varies meaningfully across them.

Vaginal cream (Estrace generic, estradiol 0.01%). The most commonly prescribed form. Applied with a calibrated applicator, typically 1 g two to three times per week for maintenance. Cash price in South Dakota averages $80 to $120 per tube (42.5 g tube lasting 4 to 8 weeks depending on dose). Cream can be messy, which reduces adherence in some patients.

Vaginal tablet (Yuvafem/generic, estradiol 10 mcg). Inserted with a disposable applicator twice weekly. Less mess than cream. Cash price in South Dakota ranges from $90 to $150 for a 30-day supply. Often preferred by insurers due to precise dosing.

Vaginal ring (Estring, estradiol 2 mg releasing 7.5 mcg/day). Inserted once every 90 days. No applicator, no daily or weekly dosing. Cash price: $200 to $400 per ring ($67 to $133 per month equivalent). Best option for patients who want minimal maintenance but carries higher upfront cost.

A 2016 Cochrane systematic review (Long et al.) assessed all three delivery forms and found no clinically significant difference in symptom relief for vaginal dryness or dyspareunia between creams, tablets, and rings [9]. Patient preference, cost, and formulary access should drive the choice.

"The choice among low-dose vaginal estrogen preparations should be guided by patient preference, ease of use, and cost, as the efficacy data show no meaningful differences between formulations," states the 2022 North American Menopause Society position statement on hormone therapy [10].

For South Dakota patients paying cash, the most cost-effective option is typically generic vaginal estradiol cream with a GoodRx or SingleCare coupon at Lewis Drug or Hy-Vee Pharmacy, where prices tend to run below the state average. For insured patients, check your formulary first. The cheapest formulation is the one your plan covers at the lowest tier.

Clinical Evidence Supporting Vaginal Estradiol for GSM

Genitourinary syndrome of menopause encompasses vaginal dryness, burning, irritation, dyspareunia, and urinary symptoms (urgency, frequency, recurrent UTIs) caused by estrogen deficiency after menopause. Unlike vasomotor symptoms, GSM does not resolve spontaneously and typically worsens over time without treatment [2].

The evidence base for vaginal estradiol is extensive. The 2016 Cochrane Review by Long et al. (CD001500) analyzed 30 randomized controlled trials involving 6,235 women and concluded that vaginal estrogen in any form effectively treated symptoms of vaginal atrophy [9]. The review found that vaginal estrogen improved vaginal maturation index, reduced vaginal pH toward premenopausal levels, and significantly reduced symptom scores for dryness and pain with intercourse.

Systemic absorption from vaginal estradiol is minimal at the doses used for GSM. A pharmacokinetic study published in Menopause demonstrated that the 10 mcg vaginal estradiol tablet maintained serum estradiol levels within the normal postmenopausal range (less than 20 pg/mL) after 52 weeks of twice-weekly use [11]. This safety profile is relevant for women with estrogen-receptor-positive breast cancer or those on aromatase inhibitors who may otherwise avoid estrogen therapy.

The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 141 recommends low-dose vaginal estrogen as first-line pharmacologic therapy for GSM [12]. ACOG notes that the minimal systemic absorption of low-dose vaginal preparations means that concurrent progestogen therapy is not required for endometrial protection, unlike with systemic estrogen therapy.

A randomized trial by Mitchell et al. (2018, N=302) published in JAMA Internal Medicine found that vaginal estradiol (10 mcg tablet) did not significantly differ from vaginal moisturizer for co-primary endpoints at 12 weeks, generating debate about first-line therapy [13]. Subsequent analysis and expert commentary noted that the trial population had relatively mild symptoms and that the study may have been underpowered for detecting differences in moderate-to-severe GSM, which is the FDA-approved indication for vaginal estradiol.

"For women with moderate to severe GSM symptoms, the evidence strongly supports low-dose vaginal estrogen therapy," noted Dr. Stephanie Faubion, Director of the Mayo Clinic Center for Women's Health and Medical Director of NAMS, in a 2023 editorial [10].

Practical Steps to Minimize Your Cost in South Dakota

Start with these concrete actions to reduce what you pay for vaginal estradiol in South Dakota.

Step 1: Check your insurance formulary. Call the number on your insurance card and ask which vaginal estradiol formulations are covered and at what tier. Request the prior authorization criteria if only non-preferred options appear.

Step 2: Compare cash prices. Use GoodRx or SingleCare to compare prices at three or more South Dakota pharmacies. Lewis Drug, Hy-Vee, and Walmart pharmacies tend to offer competitive pricing on generic formulations.

Step 3: Ask about compounding. Contact a 503A compounding pharmacy in South Dakota (Sioux Falls, Rapid City, and Aberdeen all have licensed compounders). Request a price quote for vaginal estradiol cream in the strength your prescriber recommends.

Step 4: Apply for patient assistance. If you are uninsured and your household income falls below 300% of the federal poverty level ($46,060 for an individual in 2026), apply for the manufacturer's patient assistance program.

Step 5: Consider telehealth. If you lack a local prescriber, a telehealth consultation ($50 to $150) can initiate your prescription and send it to any South Dakota pharmacy.

The standard maintenance dose for vaginal estradiol cream is 1 g intravaginally twice per week [12]. Adherence to twice-weekly dosing, rather than daily use, extends each tube's lifespan and reduces monthly cost by approximately 50% compared to daily application during the initial loading phase.